醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
IMNM · Immunome Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Immunome Inc.（IMNM）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $13.8M；高管董事有效買入 —、有效賣出 —。最近申報 2026-09-15。
買入 Bought—
賣出 Sold$13.8M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-11 | Higgins Jack Chief Scientific Officer | 賣出 Sell | 13,200 | $25.32 | $334K | SEC |
| 2026-08-10 | Barchas Isaac Director | 賣出 Sell | 83,464 | $26.35 | $2.2M | SEC |
| 2026-08-06 | Barchas Isaac Director | 賣出 Sell | 36,088 | $26.06 | $940K | SEC |
| 2026-08-04 | Horn Kinney CHIEF BUSINESS OFFICER | 賣出 Sell | 90,616 | $25.09 | $2.3M | SEC |
| 2026-07-07 | Horn Kinney CHIEF BUSINESS OFFICER | 賣出 Sell | 1,092 | $25.00 | $27K | SEC |
| 2026-07-06 | Barchas Isaac Director | 賣出 Sell | 100,000 | $24.13 | $2.4M | SEC |
| 2026-07-02 | Lechleider Robert Chief Medical Officer | 賣出 Sell | 55,000 | $22.62 | $1.2M | SEC |
| 2026-06-30 | Barchas Isaac Director | 賣出 Sell | 201,050 | $21.85 | $4.4M | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-11 | Higgins Jack Officer | 13,200 | $334K | 10b5-1 |
| 2026-08-12 | Barchas Isaac Director | 11,048 | $301K | 10b5-1 |
| 2026-08-06 | ABHMC II, LLC Shareholder | 108,504 | $2.8M | 10b5-1 |
| 2026-08-04 | Horn Kinney Officer | 90,616 | $2.3M | 10b5-1 |
| 2026-07-07 | Horn Kinney Officer | 1,092 | $27K | 10b5-1 |
| 2026-07-06 | ABHMC II, LLC Shareholder | 100,000 | $2.4M | 10b5-1 |
| 2026-07-02 | ABHMC II, LLC Shareholder | 100,000 | $2.1M | 10b5-1 |
| 2026-07-02 | Lechleider Robert Officer | 55,000 | $1.2M | 10b5-1 |
內部人 Insiders
Higgins Jack、Barchas Isaac、Horn Kinney、Lechleider Robert